1. Home
  2. AVDL vs OCSL Comparison

AVDL vs OCSL Comparison

Compare AVDL & OCSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • OCSL
  • Stock Information
  • Founded
  • AVDL 2015
  • OCSL 2007
  • Country
  • AVDL Ireland
  • OCSL United States
  • Employees
  • AVDL N/A
  • OCSL N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • OCSL Finance: Consumer Services
  • Sector
  • AVDL Health Care
  • OCSL Finance
  • Exchange
  • AVDL Nasdaq
  • OCSL Nasdaq
  • Market Cap
  • AVDL 1.4B
  • OCSL 1.2B
  • IPO Year
  • AVDL 1996
  • OCSL 2008
  • Fundamental
  • Price
  • AVDL $15.66
  • OCSL $13.41
  • Analyst Decision
  • AVDL Strong Buy
  • OCSL Hold
  • Analyst Count
  • AVDL 8
  • OCSL 6
  • Target Price
  • AVDL $20.88
  • OCSL $15.20
  • AVG Volume (30 Days)
  • AVDL 1.5M
  • OCSL 492.3K
  • Earning Date
  • AVDL 11-11-2025
  • OCSL 08-05-2025
  • Dividend Yield
  • AVDL N/A
  • OCSL 11.93%
  • EPS Growth
  • AVDL N/A
  • OCSL N/A
  • EPS
  • AVDL N/A
  • OCSL 0.55
  • Revenue
  • AVDL $221,075,000.00
  • OCSL $334,099,000.00
  • Revenue This Year
  • AVDL $64.56
  • OCSL N/A
  • Revenue Next Year
  • AVDL $30.60
  • OCSL N/A
  • P/E Ratio
  • AVDL N/A
  • OCSL $24.53
  • Revenue Growth
  • AVDL 132.35
  • OCSL N/A
  • 52 Week Low
  • AVDL $6.38
  • OCSL $12.50
  • 52 Week High
  • AVDL $16.66
  • OCSL $16.66
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 65.57
  • OCSL 40.31
  • Support Level
  • AVDL $14.78
  • OCSL $13.11
  • Resistance Level
  • AVDL $16.04
  • OCSL $14.03
  • Average True Range (ATR)
  • AVDL 0.57
  • OCSL 0.18
  • MACD
  • AVDL -0.11
  • OCSL -0.06
  • Stochastic Oscillator
  • AVDL 79.23
  • OCSL 32.26

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About OCSL Oaktree Specialty Lending Corporation

Oaktree Specialty Lending Corp is a specialty finance company. The company provides lending services and invests in small and mid-sized companies. The company's investment objective is to maximize its portfolio's total return by generating current income from debt investments, and to a lesser extent, capital appreciation from equity investments. The company provides customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets.

Share on Social Networks: